That's the goal of a bold new project between Kiwi researchers and the NZ Breast Cancer Foundation.

Water from huge genetically engineered jellyfish, food from robotic farms and cities that move with weather. Dubai has huge plans.

A new fellowship has been launched to attract global "visionary entrepreneurs" to New Zealand with up to 400 spaces available.

Scientists create a prototype for a 3D bio-printer that is capable of printing functional human skins.

Ever met someone who just wasn't into music? They might just have a condition called specific musical anhedonia.

A New Zealand medical trial involving injecting specially encapsulated pig-derived cells into human brains has passed another milestone.

Hollywood has long been fascinated with the idea of communicating with space aliens. But is it even possible? Or wise?

They're usually found inside the guts of fish: but glow-in-the-dark bugs also look great on canvas.

The SingularityU Summit kicked off on schedule in Christchurch this afternoon.

Global interest in a Kiwi company's anti-aging drug is ramping up, with three major clinical trials now under way to test it against a range of ailments.

The powerful combination of two vitamins could be a hidden key to curing human diseases through regenerative medicine.

World-renowned Australian artist Stelarc -- perhaps best known for having an artificial ear construction inserted into his arm --

Nobel Prize winners say environmental groups, led by Greenpeace, have opposed biotechnological innovation in agriculture.

A review of the health technology and medical devices sectors shows the industry has the fastest growth in IT spending.

New Zealand-founded LanzaTech has been ranked thirteenth on CNBC's Disruptors list for 2016.

Kiwi biotech firm Ubiquitome is seeking clearance from the FDA to secure a Zika diagnostic test.

Orion Health, Waitemata DHB and University of Auckland are part of a $37 million healthcare research collaboration.

Two of the 0.2mm-long creatures, and a separate egg, were able to be revived after being frozen for more than 30 years.

Last Thursday we saw a tale of two biotech companies. If you need evidence investing in medical research stocks is a lottery, this is the story for you, writes Christopher Niesche.

A process that could turn harmful gases into useful products like car tyres shows why scientists need to keep challenging our understanding of what are the proteins vital to all life on Earth.

As a species we face a conundrum: we have become so good at survival that we face sustainability issues caused by our population and consumption, Eric Watson writes.

Nasdaq's biotech companies have returned 500 per cent gains to shareholders since 2011, versus 97 per cent for the Nasdaq's Internet stocks.

A new way of treating incurable illnesses such as cancer and Ebola could be possible after a scientific breakthrough that also sheds light on the origin of life.

It costs drugmakers US$2.56 billion to bring a new medicine to market - more than double the price of 11 years ago.

New Zealand-founded bio-fuels innovator LanzaTech has attracted US$60 million in its latest capital-raising round,

Wellington's notoriously volatile weather is nothing compared with the climate Mary Quin faced in her previous home city.

The brains of patients with Parkinson's disease who had deep brain stimulation treatment produced new stem cells, according to new research.

The lines of thousands of love poems and songs may have to be rewritten, according to Professor Alain Carpentier.

Computer giant's motto is 'Don't be evil', but some worry that tech purchase brings allure of defence contracts.